Latest Articles
- Progress in preventing chemotherapy-induced nausea and vomiting
Our understanding of the pathophysiology of emesis has improved, and we now have drugs that can prevent acute emesis in most patients. Delayed and anticipatory emesis remain a challenge.
- Keeping up with medical ‘truth’
It’s now documented: by the time you retire, half of what you learned in medical school will be false or obsolete.
Two advances in the management of Parkinson diseaseSecond-generation dopamine agonists may be preferable to levodopa early in the disease. Deep brain stimulation is remarkably effective in refractory cases.
‘White coat hypertension’—should it be treated or not?Treatment is controversial, and any benefit of treatment is unproven.
- Inflammatory bowel disease: Sorting out the treatment options
Options now include aminosalicylates, steroids, azathioprine, 6-mercaptopurine, cyclosporine, methotrexate, infliximab, heparin, and perhaps even antimicrobials and nicotine. How to choose?
- Asymptomatic hyperuricemia: To treat or not to treat
Most people with asymptomatic hyperuricemia do not need further workup or treatment. Who are the exceptions?
- Hyperuricemia and gout: A reign of complacency
We physicians have become complacent about gouty arthritis, developing a false sense of confidence that we actually know how to manage it.
